Vaccine

Article	Citations
Editorial Board/Aims and Scope	795
Referring to: Wilkinson K, Righolt CH, Elliott LJ, Fanella S, Mahmud SM. Pertussis vaccine effectiveness and duration of protection – a systematic review and meta-analysis. Vaccine. 2021 May 27;39(23)	489
Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques	387
RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice	371
Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics	306
Economic evaluation of high-dose inactivated influenza vaccine in adults aged ≥65 years: A systematic literature review	212
Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign	187
Vaccine value profile for Shigella	181
List of abbreviations and acronyms used in Vaccine Value Profiles	172
A non-toxic recombinant bivalent chimeric protein rETXm3CSAm4/TMD as a potential vaccine candidate against enterotoxemia and braxy	165
A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immun	156
Cost of illness due to pertussis in adults ≥50 years of age in the United Kingdom	146
COVID-19 vaccination in the Federal Bureau of Prisons, December 2020—April 2021	141
Editorial Board/Aims and Scope	140
Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden	140
Exploring the ethics of using fictional stories for health education on social media to share information and emotions about the HPV vaccine: A cross-sectional study with interdisciplinary health expe	138
Editorial Board/Aims and Scope	138
Long-term predominance in childhood colonization of the multidrug-resistant lineage 6C/ST386 of Streptococcus pneumoniae after universal immunization with the 10-valent pneumococcal conjugate vaccine	128
Vaccination during febrile illness, what do we know? A systematic-narrative hybrid review of the literature and international recommendations	122
Raising the case of hepatitis E: Report from the 2nd international HEV symposium	119
Enhancing HPV vaccine uptake in girls and boys – A qualitative analysis of Canadian school-based vaccination programs	117
Virtual reality for routine immunisations in needle phobic children with and without developmental disabilities: A pilot study	116
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study	109
Emerging global patterns of COVID-19 vaccine information fatigue in 23 countries in 2023	109
MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settings	108

Changes in population genetic structure of serotype 19A Streptococcus pneumoniae after universal childhood use of the 10-valent pneumococcal conjugate vaccine in Brazil	107
Meeting summary: Global vaccine and immunization research forum, 2023	97
A framework for monitoring RSV prevention product effectiveness in the United States	94
Recombinant zoster vaccine and the risk of dementia	89
Raman spectroscopy as a tool for detection of lung cancer and verification of vaccination effect – Correlation with biochemical data	88
“They need to speak a language everyone can understand”: Accessibility of COVID-19 vaccine information for Canadian adults with intellectual and developmental disabilities	85
Immunization and challenge trials in a murine model using different inactivated recombinant vaccines against H1N1 swine influenza virus circulating in Brazil	85
Cost-effectiveness of anti-viral treatment for infants with RSV disease in the United Kingdom	82
Navigating the future of vaccination strategies: Insights from the 17th annual vaccine congress	81
Corrigendum to Assessment of the Bnt162b2 covid-19 vaccine immune response in Brazilian indigenous adolescents. Vaccine Volume 43, Part 1, 1 January 2025, 126494	79
Moderate effectiveness of influenza vaccine in outpatient settings: A test-negative study in Beijing, China, 2023/24 season	78
Knowledge, attitudes, and practices of healthcare providers regarding vaccinating children with cancer in Latin America and the Caribbean	78
Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: A cross-sectional	76
Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines	74
Impact of the COVID-19 pandemic on routine childhood vaccination in 9 U.S. jurisdictions	73
Editorial Board	72
Influenza vaccine uptake among youth with sickle cell disease who are seen in clinic before and after the COVID-19 pandemic	72
Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine	71
Long-term impact of rotavirus vaccination on all-cause and rotavirus-specific gastroenteritis and strain distribution in Central Kenya: An 11-year interrupted time-series analysis	71
Longevity of serologic responses following a single dose of typhoid conjugate vaccine among children living with HIV in Pakistan: A prospective cohort study	70
Dynamics of multisystem inflammatory syndrome in children associated to COVID-19 in Chile: Epidemiologic trends during pandemic, before and after children vaccination	70
Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria	70
Corrigendum to “Sustainability of measles, rubella, and congenital rubella syndrome (CRS) elimination in the United States, January 2022 – June 2024” [Vaccine 46C (2025) 126681]	68
Corrigendum to “A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy i	68
Closing the gap on vaccine uptake in developing countries: Is there a role for cash incentives?	67
Real-world evidence of yellow Fever vaccination data-driven study	65
Prolonged immune response to tick-borne Ehrlichia chaffeensis infection using a genetically modified live vaccine	63
Reverse vaccinology: A strategy also used for identifying potential vaccine antigens in poultry	62
Intervention-amenable factors associated with lack of HPV vaccination in Kenya: Results from a large national phone survey	62
Modelling the impact and cost-effectiveness of upcoming Zika virus vaccines on congenital Zika syndrome	62
Long-term antibody trajectories after PPSV23 in elderly: Results from a 4-year follow-up study	62
Association between parental vaccine hesitancy and geographical coverage for childhood vaccination: A cross-sectional study	61
Exploring the delivery of adult vaccination outside of primary care settings: A mixed methods scoping review	61
Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus c	59
Effectiveness of the ten- and thirteen-valent pneumococcal conjugate vaccines to prevent serotype 19A invasive pneumococcal disease in Quebec, Canada. A Canadian immunization research network (CIRN) s	59
FTIR monitoring of the 13-valent pneumococcal conjugate vaccine for lung cancer patients: Changes in amides vibrations correlated with biochemical assays	58
Oral paratuberculosis vaccine efficacy and mucosal immunity in cattle	58
Comparable and sustained levels of S1-RBD-IgG and S1-RBD-IgA in BNT162b2 homologous and CoronaVac-BNT162b2 heterologous booster vaccination: A 22-month prospective study in Malaysia	57
Editorial Board/Aims and Scope	56
Editorial Board/Aims and Scope	55
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates	55
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysacchar	55
Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: A randomized controlled trial	54
Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies	54
Editorial Board/Aims and Scope	53
The Brighton Collaboration standardized templates for collection of key information for benefit-risk assessment of vaccines by technology (BRAVATO; formerly V3SWG)	52
Editorial Board/Aims and Scope	52
Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule: Response letter, to letter to the edit	52
Beyond the numbers: An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses	51
Linking cohort data and Welsh routine health records to investigate children at risk of delayed primary vaccination	51

Antigen presentation by Follicular Dendritic cells to cognate B cells is pivotal for Generalised Modules for Membrane Antigens (GMMA) immunogenicity	51
A getah virus-like-particle vaccine provides complete protection from viremia and arthritis in wild-type mice	51
Predicting COVID-19 vaccination intention using protection motivation theory and conspiracy beliefs	50
Social and demographic patterns of influenza vaccination coverage in Norway, influenza seasons 2014/15 to 2020/21	50
COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization	50
Reduced cell-mediated immune response in hyperglycemic NOD mice following influenza vaccination	50
Racial and ethnic disparities in COVID-19 vaccine uptake: A mediation framework	50
Country immunization policies for refugees across 20 low-middle income and 20 high-income countries	49
Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey	48
“You Have to Die Not to Come to Work”: A Mixed Methods Study of Attitudes and Behaviors regarding Presenteeism, Absenteeism and Influenza Vaccination among Healthcare Personnel with Respiratory Illnes	48
Editorial Board/Aims and Scope	48
Editorial Board/Aims and Scope	48
Systematic review and meta-analysis of the effect of pertussis vaccine in pregnancy on the risk of chorioamnionitis, non-pertussis infectious diseases and other adverse pregnancy outcomes	48
Education increases COVID-19 vaccine uptake among people in Canadian federal prisons in a prospective randomized controlled trial: The EDUCATE study	48
Significant gaps in hepatitis B vaccination in adults in Viet Nam: Important targets toward hepatitis B elimination by 2030	48
Using geographic information system to track children and optimize immunization coverage and equity in Karachi, Pakistan	47
Disparities in COVID-19 vaccine uptake among health care workers	47
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines	46
Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems	45
Editorial Board/Aims and Scope	45
Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination	45
Editorial Board/Aims and Scope	44
Editorial Board/Aims and Scope	44
Editorial Board/Aims and Scope	44
Pacific Eclipse: Before the corona dawn	44
A humanized monoclonal antibody targeting protein a promotes opsonophagocytosis of Staphylococcus aureus in human umbilical cord blood	43
Development of a platform-based approach for the clinical production of HIV gp120 envelope glycoprotein vaccine candidates	43
A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult l	43
Immunization with a tri-antigen syphilis vaccine significantly attenuates chancre development, reduces bacterial load, and inhibits dissemination of Treponema pallidum	42
Parental health beliefs, intention, and strategies about covid-19 vaccine for their children: A cross-sectional analysis from five Arab countries in the Middle East	42
A user-centered approach to developing a new tool measuring the behavioural and social drivers of vaccination	42
Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients	41
Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis	41
Immunogenicity and protective efficacy of a trimeric full-length S protein subunit vaccine for porcine epidemic diarrhea virus	41
Cost-benefit analysis of vaccination against four preventable diseases in older adults: Impact of an aging population	41
Estimating county-level vaccination coverage using small area estimation with the National Immunization Survey-Child	40
Immunogenicity and persistence of high-dose recombinant hepatitis B vaccine in adults infected with human immunodeficiency virus in China: A randomized, double-blind, parallel controlled trial	40
Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data	40
Long-term surveillance of invasive pneumococcal disease: The impact of 10-valent pneumococcal conjugate vaccine in the metropolitan region of Salvador, Brazil	40
Pneumonia hospitalization after introduction of pneumococcal conjugate vaccine in Japan: Descriptive study using a nationwide claims database	40
Introducing ROTAVAC® to the occupied Palestinian Territories: Impact on diarrhea incidence, rotavirus prevalence and genotype composition	40
Understanding reporting practices and perceptions of barriers in adverse events following immunisation surveillance: A cross–sectional survey of paediatricians in Kerala, India	40
How COVID exposed the hypocrisy within me	39
Humoral and cellular immune response to tick-borne-encephalitis (TBE) vaccination depends on booster doses in patients with Juvenile Idiopathic Arthritis (JIA)	39
Editorial Board/Aims and Scope	39
Estimating vaccination coverage for routinely recommended vaccines among children aged 24 months and adolescents aged 13 through 17 years using data from immunization information systems in the United	39
Moving vaccination beyond partisan politics	39
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental chal	39
The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process	39
Working towards a sustainable, healthy market for vaccines: A framework to support evidence-based policymaking	38
Pacific Eclipse exercise: Value to US Indo-Pacific Command Surgeon’s Office	38
A comparison of two Fendrix hepatitis B vaccination schedules in patients with inflammatory bowel disease	37
Hospital-based sentinel surveillance for bacterial meningitis in under-five children prior to the introduction of the PCV13 in India	37
Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort	37
COVID-19 vaccine hesitancy: Lessons from Israel	36
Modeling the optimal seasonal monoclonal antibody administration strategy for respiratory syncytial virus (RSV) prevention based on age-season specific hospitalization rate of RSV in Suzhou, China, 20	36
The impact of Facebook’s vaccine misinformation policy on user endorsements of vaccine content: An interrupted time series analysis	36
The economics of global COVID vaccine administration during a pandemic – Why continue skin alcohol preparation as a costly but ineffective practice?	36
Cost-effectiveness of the 20-valent pneumococcal conjugate vaccine versus the 23-valent pneumococcal polysaccharide vaccine for older adults in South Korea	36
Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria	36
Influenza immune imprinting synergizes PEI-HA/CpG nanoparticle vaccine protection against heterosubtypic infection in mice	36
Editorial Board/Aims and Scope	36
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study	36
Acute reactions after a homologous primary COVID-19 vaccination series: Analysis of Taiwan V-Watch data	35
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants	35
Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998–2019	35
Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo	35
Clinical endpoints to inform vaccine policy: A systematic review of outcome measures from pediatric influenza vaccine efficacy trials	35
Factors associated with humoral immune response in older adults who received egg-free influenza vaccine	35
Editorial Board/Aims and Scope	35
Timeliness in the uptake of hepatitis B birth dose among Indian children under age five: A population-based study	34
Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate	34
Socio-demographic determinants of COVID-19 vaccine uptake in Ontario: Exploring differences across the Health Region model	34
Editorial Board/Aims and Scope	34
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women	34
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection	34
Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study	34
Nonclinical safety assessment and immunogenicity of rVSVInd(GML)-mspSGtc vaccine for SARS-CoV-2 in rabbits	33
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies	33
Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity	33

Serological response with Heplisav-B® in prior Hepatitis B vaccine non-responders living with HIV	33
Variation in incidence rates of outcomes relevant to vaccine safety monitoring in a US commercially insured population by case identification algorithm	33
The association between parental and neonatal BCG vaccination and neonatal T helper 17 cell expansion	33
Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received tw	33
Rational design and production of a chimeric antigen targeting Zika virus that induces neutralizing antibodies in mice	32
Inequalities in coverage of COVID-19 vaccination: A population register based cross-sectional study in Wales, UK	32
Exploring key informants’ perceptions of Covid-19 vaccine hesitancy in a disadvantaged urban community in Ireland: Emergence of a ‘4Cs’ model	32
Does BCG provide long-term protection against SARS-CoV-2 infection? A case–control study in Quebec, Canada	32
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial	32
Preventing severe influenza in Australian infants: Maternal influenza vaccine effectiveness in the PAEDS-FluCAN networks using the test-negative design	32
Expression kinetics of cytokines and the humoral antibody response concerning short-term protection induced by radiation-attenuated Trypanosoma evansi in bovine calves	32
Conspiracies, misinformation and resistance to public health measures during COVID-19 in white nationalist online communication	32
Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia	32
Understanding the role of personal experiences and contextual variables in shaping risk reduction preferences	31
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021	31
Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding	31
Editorial Board/Aims and Scope	31
HPV vaccination acceptance and perceptions related to fertility and population control in the Gambia: An anthropological analysis	31
Pneumococcal serotypes and antibiotic resistance in healthy carriage children after introduction of PCV13 in Lima, Peru	31
Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies	31
Placing a value on increased flexible vaccine manufacturing capacity for future pandemics	30
Modelling a cost-effective vaccination strategy for the prevention of varicella and herpes zoster infection: A systematic review	30
Collateral damage from debunking mRNA vaccine misinformation	30
Short term safety of BNT162b2 (Pfizer–BioNTech) SARS-CoV-2 vaccine among children aged 5–11 years, a nationwide parental survey	30
Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model	30
Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study	30
Comment on “Vila-Córcoles et al., Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015–2016.“	29
Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest	29
The impact of universal varicella vaccination on the clinical burden of varicella in Colombia: A National database Analysis, 2008–2019	29
Editorial Board	29
Readability of COVID-19 vaccine information for the general public	29
Psychological determinants of COVID-19 vaccine acceptance: A comparison between immigrants and the host population in Japan	29
Subcutaneous nodule at the vaccine injection site – A case of mistaken identity	29
Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2/Th17 profile and high antibody levels	29
Immunity debt or vaccination crisis? A multi-method evidence on vaccine acceptance and media framing for emerging COVID-19 variants	29
TAK − 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice	28
“Who is Anders Tegnell?” Unanswered questions hamper COVID-19 vaccine uptake: A qualitative study among ethnic minorities in Sweden	28
Evaluation of the reliability and validity of a vaccine hesitancy scale on knowledge, attitude, trust and vaccination environment (KATE-S) in Chinese parents	28
Promotion of healthcare personnel vaccinations among newly employed doctors and nurses: Evidence-guided strategy	28
Use of an adapted participatory learning and action cycle to increase knowledge and uptake of child vaccination in internally displaced persons camps (IVACS): A cluster-randomised controlled trial	28
Analyzing an immunization resource website: User browsing trends	28
Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic	28
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys	27
Complementary medicine use and flu vaccination – A nationally representative survey of US adults	27
Issues with infectious disease vaccine introduction into routine vaccination in Japan, and considerations for accelerating the process	27
Reassurance of population immunity to diphtheria in England: Results from a 2021 national serosurvey	27
One-year follow-up of the immunogenicity and safety of a primary series of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Final report of a phase I/II randomized controlled trial	27
The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies	27
Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children	27
Editorial Board/Aims and Scope	27
Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis	27
Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults	27
Editorial Board/Aims and Scope	27
Vaccination with a fowl adenovirus chimeric fiber protein (crecFib-4/11) simultaneously protects chickens against hepatitis-hydropericardium syndrome (HHS) and inclusion body hepatitis (IBH)	27
Enhancement of live vaccines by co-delivery of immune modulating proteins	26
Editorial Board/Aims and Scope	26
Sexual orientation was associated with intention to be vaccinated with a smallpox vaccine against mpox: A cross-sectional preliminary survey in Japan	26
Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data	26
The safety of seasonal influenza vaccination among adults prescribed immune checkpoint inhibitors: A self-controlled case series study using administrative data	26
Letter to the editor	26
Editorial Board/Aims and Scope	26
The correlation between conspiracy mentality and vaccine intentions is moderated by social events: Evidence from longitudinal data during COVID-19 pandemic in the UK	26
Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India	26
Managing multiplicity in clinical vaccine studies – A case study using a gatekeeping testing strategy	26
Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: A prospective population-based study in rural Bangladesh	26
Systematic review of the costs for vaccinators to reach vaccination sites: Incremental costs of reaching hard-to-reach populations	26
Literature review to identify evidence of secondary transmission of pentavalent human-bovine reassortant rotavirus vaccine (RV5) strains to unvaccinated subjects	26
Editorial Board/Aims and Scope	25
Childhood vaccination timeliness following maternal migration to an informal urban settlement in Kenya	25
Validation of algorithms using International Classification of Diseases for the identification of herpes zoster episodes requiring hospitalization in Quebec, Canada	25
Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016–2019	25
Trust and science: Public health’s home field advantage in addressing vaccine hesitancy and improving immunization rates	25
Tackling the burden of mumps in the military: A report of the Defense Health Board	25
Mass vaccination campaign during the 2016 influenza outbreak in Panama: Challenges and implications for COVID-19 vaccination efforts	25
Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate	25
Editorial Board/Aims and Scope	25
Editorial Board/Aims and Scope	25
Burden of rotavirus disease in young children in Iceland – Time to vaccinate?	25
Association between vaccination status, symptom identification and healthcare use: Implications for test negative design observational studies	25
Non-linear relationships between children age and pneumococcal vaccine coverage: Important implications for vaccine prevention strategies	25
Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March–October, 2021	25
The second annual Vaccination Acceptance Research Network Conference (VARN2023): Shifting the immunization narrative to center equity and community expertise	24
Impact of respiratory syncytial virus on older children: Exploring the potential for preventive strategies beyond the age of 2 years	24
Role of rotavirus vaccine in reducing diarrheal episodes in infants visiting private primary health care clinics in Karachi, Pakistan: A mixed-methods study	24
Rift Valley Fever vaccine strategies: Enhanced stability of RVF Clone 13	24
Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccines	24
Gut membrane proteins as candidate antigens for immunization of mice against the tick Amblyomma sculptum	24
Effectiveness of the varicella vaccine in the real world, a matched case-control study	24
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age	24
Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice	24
Accelerating access for all through research and innovation in immunization: Recommendations from Strategic Priority 7 of the Immunization Agenda 2030	24
Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: A pre-post comparison study	24
Pediatric otitis media in Japan: A nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010	24
Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection	24
A J Paramyxovirus-vectored HIV vaccine induces humoral and cellular responses in mice	23